BKBG
MACK

BHF Kleinwort Benson Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

BHF Kleinwort Benson Group’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,442
Closed -$117K – 325
2013
Q2 		$117K Buy
+2,442
New +$107K 0.01% 202

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BHF Kleinwort Benson Group's MACK Position: Q3 2013 in Review

BHF Kleinwort Benson Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2013, closing a stake of 2,442 shares — an estimated $117K sold.

BHF Kleinwort Benson Group first reported a position in MACK in Q2 2013 and held it in 1 quarter. The position peaked at $117K in Q2 2013. 95 funds tracked by Wall St. Rank hold MACK as of Q3 2013.

  • BHF Kleinwort Benson Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • BHF Kleinwort Benson Group sold 2,442 Merrimack Pharmaceuticals, Inc. shares in Q3 2013, an estimated $117K.
  • BHF Kleinwort Benson Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • BHF Kleinwort Benson Group's Merrimack Pharmaceuticals, Inc. position peaked at $117K in Q2 2013.
  • 95 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2013.

Based on BHF Kleinwort Benson Group's 13F filing for Q3 2013, filed 18 Dec 2013.